Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
Clinical trial NCT01594281 · COMPLETED
Trial details
- NCT number
- NCT01594281
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-11
- Primary completion
- 2016-11-30
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.